Market Overview

Pfizer Warns U.K. Doctors About Prescribing Generic Lyrica For Pain

Share:

Pfizer Inc. (NYSE: PFE) "has written to physician groups in the U.K. to warn that prescribing generic versions of its Lyrica medicine – specifically, for treating pain – would violate its patent," according to the Wall Street Journal.

"Pfizer believes the supply of generic pregabalin for use in the treatment of pain whilst the pain patent remains in force in the U.K. would infringe Pfizer’s patent rights," Ruth Coles, the Pfizer legal director in the U.K., writes in the letter. "This would not be the case with supply or dispensing of generic pregabalin for non-pain indications."

Pfizer indicated that the issue is a legal matter rather than a clinical one and it is concerned about its patent rights.

Pfizer recently traded at $32.61, down 0.47 percent.

Posted-In: Wall Street JournalNews Media

 

Related Articles (PFE)

View Comments and Join the Discussion!
Fastest Market News Application
You'll Hear It First On Pro
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Why This NYSE Floor Trader Is Warning Against Transocean

Should Facebook Still Try To Build A Smartphone?